It is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS) in the U.S. three months of age and older and in Europe for patients two months of age and older.

In unusual circumstances, Ipsen has been given the green light for its odevixibat drug for severe itching (pruritus) in patients with rare liver disease Alagille syndrome (ALGS) in the EU – for ...

He was just a day old when he was diagnosed with a genetic disease called Alagille syndrome, a condition that leads to liver failure. Orlando was placed on a transplant list as a baby, and after an ...

LIVMARLI is the first and only treatment available for cholestatic pruritus in patients with Alagille syndrome and Progressive Familial Intrahepatic Cholestasis in Japan Mirum Pharmaceuticals ...

Mirum announced the FDA approved a new tablet formulation of Livmarli for the treatment of cholestatic pruritus in patients with Alagille syndrome and progressive familial intrahepatic cholestasis.

He was just a day old when he was diagnosed with a genetic disease called Alagille syndrome, a condition that leads to liver failure. Orlando was placed on a transplant list as a baby, and after ...

A ribbon cutting was held on April 16 for FedUp Foods in the former Tru Colors Brewery Building on Greenfield Street. The kombucha and cold brew coffee company eventually expects to employ around 100 ...

To answer this, researchers from Karolinska Institutet and Charles University studied a genetic disease called Alagille syndrome, which is characterized by surprisingly mild liver fibrosis despite ...

A couple of years later, Grey was at a fundraiser for the Alagille Syndrome Alliance, one of the patient advocacy groups that had been actively engaged in the original clinical trials, and he ...

and Alagille syndrome (ALGS). Its flagship product, Livmarli (maralixibat), is approved for treating cholestatic pruritus in pediatric ALGS patients, contributing to the company’s revenue.